Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.
about
Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study.Clinical Relevance and Predictive Value of Damage Biomarkers of Drug-Induced Kidney Injury.Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury.Effects of atorvastatin on biomarkers of acute kidney injury in amikacin recipients: A pilot, randomized, placebo-controlled, clinical trial.Differences in acute kidney injury ascertainment for clinical and preclinical studies.Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.Diagnostic accuracy of urinary biomarkers in infants younger than 3 months with urinary tract infection.HSP72 is an early biomarker to detect cisplatin and acetaminophen nephrotoxicity.Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-dependent Changes in the Absence of Clinical Nephrotoxicity.Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.Persistent expression of neutrophil gelatinase-associated lipocalin and M2 macrophage markers and chronic fibrosis after acute kidney injury.Predicting Acute Renal Injury in Cancer Patients Receiving Cisplatin Using Urinary Neutrophil Gelatinase-Associated Lipocalin and Cystatin C.
P2860
Q37652392-03412419-AD24-462A-A7B9-8834EC751865Q38694959-3B7400DE-90C1-4CEA-AF46-A23995CA227DQ38793821-8CFC79F2-66F7-4799-AD50-FC910C43500DQ38807936-E0186E22-7740-471E-9AF9-A63DE5FB5F7EQ39216951-5A071061-6837-4A0A-83A5-9AF9C7734EA5Q47303561-8BA07A3C-F8EF-4AF2-A515-9E86E5C81CCFQ50022866-0B711CA3-FD36-44E9-A716-1FDD785A7C48Q50738925-F9021889-3461-438E-8122-5B1116322CE2Q50996833-E6DE8907-4192-4C51-AD66-1F328C94AD58Q51113993-FF71A43C-7741-4E38-9CE8-05F80CB509A8Q55025513-1AA34BF9-9C36-4FF8-9CB7-E926943A8144Q55711132-EB1063D6-6084-4CBE-8300-BF179259C51F
P2860
Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Urinary kidney injury molecule ...... icity in lung cancer patients.
@ast
Urinary kidney injury molecule ...... icity in lung cancer patients.
@en
type
label
Urinary kidney injury molecule ...... icity in lung cancer patients.
@ast
Urinary kidney injury molecule ...... icity in lung cancer patients.
@en
prefLabel
Urinary kidney injury molecule ...... icity in lung cancer patients.
@ast
Urinary kidney injury molecule ...... icity in lung cancer patients.
@en
P2093
P2860
P1476
Urinary kidney injury molecule ...... icity in lung cancer patients.
@en
P2093
Aiko Ozawa
Haruka Shinke
Joseph V Bonventre
Kazuo Matsubara
Michiaki Mishima
Satohiro Masuda
Takaharu Ichimura
Tomoko Sato
Yasuaki Ikemi
Young Hak Kim
P2860
P2888
P304
P356
10.1007/S00280-015-2880-Y
P577
2015-09-25T00:00:00Z